摘要
目的观察吸入肾上腺皮质激素联合长效β_2受体激动剂治疗儿童支气管哮喘的临床疗效。方法选取我院2014年7月至2015年12月收治的118例支气管哮喘患儿,随机分为观察组和对照组,各59例。两组患儿均给予吸氧、抗感染、止咳化痰等常规治疗,对照组在常规治疗基础上单纯吸入肾上腺皮质激素治疗,观察组则加用长效β_2受体激动剂治疗。对比两组患儿的临床疗效和症状消失时间。结果观察组的总有效率为93.22%,明显高于对照组的77.97%(P<0.05)。观察组的症状消失时间明显短于对照组(P<0.05)。结论吸入肾上腺皮质激素联合长效β_2受体激动剂治疗儿童支气管哮喘具有显著疗效,可有效缓解临床症状,提高治疗效果,值得临床推广应用。
Objective To observe the clinical effect of inhaled adrenocortical hormone combined with long-term 82 receptor agonist in the treatment of children with bronchial asthma. Methods 118 cases of children with bronchial asthma admitted to our hospital from July 2014 to December 2015 were selected and randomly divided into observation group and control group, with 59 cases in each group. Both groups were given conventional treatment, including oxygen inhalation, anti-infection, preventing phlegm and stopping cough. On the basis of the conventional treatment, the control group only received inhaled adrenocortical hormone, while the observation group received long-term β2 receptor agonist additionally. The clinical effect and symptom disappearance time were compared between two groups. Results The total effective rate of observation group was 93.22%, significantly higher than 77.97% of control group （P 〈0.05）. The symptom disappearance time of observation group was significantly shorter than that of control group （P 〈0.05）. Conclusions Inhaled adrenocortical hormone combined with long-term β2 receptor agonist in the treatment of children with bronchial asthma has significant effect, can effectively relieve clinical symptoms and improve curative effect, which is worthy of clinical promotion and application.
出处
《临床医学工程》
2017年第5期625-626,共2页
Clinical Medicine & Engineering
